Roth MKM analyst Justin Clare maintained a Buy rating on Atkore International Group (ATKR – Research Report) today and set a price target of ...

Roth/MKM analysts reinstated coverage on PLBY Group, Inc. (NASDAQ: PLBY) with a Buy rating and set a price target of $3.00, ...

We recently published a list of 12 Most Buzzing Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

Analyst Shen discusses Enphase Energy ( ENPH) Q4:24 results on an Analyst/Indusry conference call to be held on February 5 at 8:45 am. Webcast Link ...

Research analysts at Roth Capital upped their Q1 2025 earnings per share estimates for shares of Viper Energy in a research ...

Investment analysts at Roth Capital lifted their Q1 2026 earnings per share estimates for shares of Polaris in a note issued ...

PLBY Group (PLBY) is jumping 20% today after the company announced that it was converting 25% of its preferred shares to ...

Roth MKM keeps a Buy rating on Imax (IMAX) with a $28 price target after the company signed an exclusive, worldwide deal with ...

https://www.tipranks.com/news/the-fly/anavex-price-target-raised-to-42-from-40-at-h-c-wainwright Roth MKM lowered the firm’s price target on CervoMed (CRVO) to $4 ...

As of December 3, 2024, the average one-year price target for CervoMed is $54.74/share. The forecasts range from a low of $34.34 to a high of $73.50. The average price target represents an ...